Flow Cytometry System Market

Global Flow Cytometry System Market by Technology (Cell-based Flow Cytometry System, Bead Based Flow Cytometry System), Products and Services (Reagents and Consumables, Instruments, Software, Services, and Accessories), Applications (Research Applications, Clinical Applications, and Industrial Applications), Research Applications (Pharmaceuticals and Biotechnology, Immunology, Cell Sorting, Apoptosis, Cell Cycle Analysis, Cell Viability, Cell Counting, and Others) and Region (North America, Latin America, Europe, Asia Pacific and Middle East & Africa)

  • Report ID: HC-166
  • Author: Growth Market Reports
  • Rating: 4.9
  • Total Reviews: 24
  • No. Of Pages: 300
  • Format:
  • Pub. Date: 11-11-2020
  • Share:

Market Outlook:

The global flow cytometry system market was valued at USD 4,298.1 Million in 2019 and is projected to reach USD 9,452.6 Million by 2027, expanding at a CAGR of 10.0% during the forecast period. Flow cytometry is technique, which is used to measure the physical and chemical characteristics of cells. Flow cytometry systems are the instruments, which are used for analyzing the quantitative of cells and for analyzing chromosomes, m-RNA, recombinant proteins, and other molecules, which are suspended in a fluid. Flow cytometry technique is based on the principle of the measurement of scattering of light by the particles. The fluorescence light is passed through the cell. The deflection of the light occurs, according to the complexity and size of the particle. Forward-scattered light (FSC), and side-scattered light (SSC) are two methods of deflecting the light. The measurements of FSC and SSC are used for the differentiation of cell types in a heterogeneous cell suspension, while fluorescent markers are used for determining the proteins or nucleic acids. Fluorescence pattern of each cell suspension, which are mixed with FSC and SSC, can be used to identify the cells and to count their percentage. For the detection of specific antibodies, cells are coated with fluorochrome-conjugated antibodies specific to the surface markers present on different cells. Flow cytometry techniques are used for identifying hematological malignancies. Cell size, granularity of the cell, and intracellular proteins can be identified using flow cytometry. Flow cytometry systems are used for precise analysis of small population of cells at high speed.

Global Flow Cytometry System Market Key Takeaways

Market Dynamics
Drivers
Increased Use of Artificial Intelligence (AI) in Flow Cytometry Systems

The advent of new technology, has led to the adoption of the artificial intelligence (AI) for the detection and separation of the cells, molecules, and deoxyribonucleic acid (DNA), using a software, which is used in the flow cytometry systems process. AI is used in analyzing the images, and also interprets the complex data. Artificial intelligence uses programs and algorithms for the separation and analysis of cells. AI, using the deep learning algorithms, simplifies the multimodal images, and reduces the variability in the data. The reduction in the variability in the data, enhances the quality of the data. The use of imaging flow cytometry systems combines brightfield, darkfield, and fluorescence-based detection all in one platform. AI, finds its use in several applications, including, studies designed to monitor multiple subcellular compartments, or to locate and quantify the distribution of signaling molecules on, in, or between cells. Technological advancements and rise in the adoption of the AI in biotechnology and pharmaceutical industries are some of the factors, which boosts the adoption of AI in flow cytometry.

Increase in Government Funding for Pharmaceutical and Biotechnology Companies
Governments are investing in research for the development of novel drugs and techniques for determining vaccines and drugs, thus boosting research and development (R&D) in the pharmaceutical and biotechnology industries. The investments boost the development of innovative products. Several research biotechnology and pharmaceutical companies have installed flow cytometers for the detection of recombinant proteins, and cell cycles. Government investments reduce the burden on drug manufacturing companies, thus boosting the adoption of the flow cytometers. The government of the UK, has increased funding for R&D. The government is focusing on the development of new drugs for biosimilars and personalized medicines, which boost the adoption of flow cytometers for the determination of mechanism of action of the drugs.

Restrains
High Costs of Flow Cytometry Systems

Flow cytometers are widely used in pharmaceutical and biotechnology companies, for the manufacturing of drugs. Flow cytometers are used for the monitoring of diseases and are used in the diagnostic centers and hospitals. High costs of the flow cytometers is one of the major factor, which hampers the demand for the flow cytometers. Large amount of capital is required for the purchase of the flow cytometers. Several companies have funding limitations, which hampers the demand for the flow cytometers. Costs of the reagents, which are used for the detection of antibodies, are also high, which hampers the demand for the flow cytometers. These are some of the factors, which hinders the demand for the flow cytometers.

Dearth of Skilled Professionals
Dearth of skilled personnel is one of the major factors which hampers the market. Flow Cytometry Systems requires qualified personnel for analysis of the molecules, during the flow cytometry process. Skilled personnel is required for the implementation of new techniques. However, several people are unqualified or under skilled for the processes, thus hampering the market. Several workers are unaware of the process and this may have an impact on the final products. The dearth of skilled labors is among the major factor, which hampers the adoption of glow cytometers in research institutes and organizations.

Segmental Outlook

On the basis of technology, the market is segmented into cell-based flow cytometry system, and bead- based flow cytometry systems. The cell-based flow cytometry systems accounted for 78.9% share of the market in 2019. The rapid growth of the segment is attributed to the rise in the demand for the analysis of the cells, and identification of the cell population which are some of the factors, which contributes for the growth of the segment. Additionally, the cell-based flow cytometry system is widely available and convenient to use, which is one of the factors, which contributes for the growth of the market.

Global Flow Cytometry System Market By Application

In terms of products and services, the global flow cytometry systems market is divided into reagents and consumables, instruments, services, software, and accessories. The instruments segment is sub-segmented into cell analyzers and cell sorters. Reagents, and consumables segment is anticipated to expand at a CAGR of 10.4% during the forecast period. Rise in the use of the reagents, and consumables, for the detection of the antibodies, which are some of the factors, which contributes for the demand for the reagents and consumables.

Global Flow Cytometry System Market By Research

Based on applications, the global flow cytometry systems market is divided into research applications, immunology, clinical applications, and industrial applications. The research applications segment is further segregated into pharmaceutical and biotechnology, drug discovery, stem cell research, and in-vitro toxicity. The pharmaceutical and biotechnology segment is anticipated to account for a significant share of the market during the forecast period, while the drug discovery segment is estimated to expand at a substantial CAGR during the forecast period. Based on research applications, the market is segmented into cancer diagnostics, hematology, immunodeficiency diseases, organ transplantation, and other clinical applications. Cancer diagnostic segment is expected to have a significant share of the market, owing to the rise in the prevalence of cancer, which has led to the rise in the adoption of the flow cytometry systems for the prognosis of the diseases.

In terms of end-users, the global flow cytometry systems market is segregated into commercial organizations, hospitals, academic institutes, and clinical testing labs. The clinical testing labs segment is projected to constitute a large share of the market during the forecasts period, while the hospitals segment is anticipated to expand at significant pace during the forecast period. Flow cytometry systems techniques is used for the analysis of the diseases. Flow cytometers are used to diagnose various types of cancer, which in turn, boost their adoption in the hospitals.

Regional Outlook

In terms of regions, the global flow cytometry system market is fragmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. The market in the Asia Pacific is projected to expand at a CAGR of 10.9% during the forecast period. Rise in presence of several manufacturers, is thereby boosting the growth of the flow cytometry system market in Asia Pacific.

Global Flow Cytometry System Market By Region

Key Benefits for Industry Participants & Stakeholders

  • In-depth Analysis of the Global Flow cytometry system Market
  • Historical, Current and Projected Market Size in terms of Value
  • Potential & Niche Segments and Regions Exhibiting Promising Growth Covered
  • Industry Drivers, Restraints and Opportunities Covered in the Study
  • Recent Industry Trends and Developments
  • Competitive Landscape & Strategies of Key Players
  • Neutral Perspective on Global Flow cytometry system Market Performance
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Flow Cytometry System Market Overview
   4.1 Introduction
      4.1.1 Market Taxonomy
      4.1.2 Market Definition
      4.1.3 Macro-Economic Factors Impacting the Market Growth
   4.2 Flow Cytometry System Market Dynamics
      4.2.1 Market Drivers
      4.2.2 Market Restraints
      4.2.3 Market Opportunity
   4.3 Flow Cytometry System Market - Supply Chain Analysis
      4.3.1 List of Key Suppliers
      4.3.2 List of Key Distributors
      4.3.3 List of Key Consumers
   4.4 Key Forces Shaping the Flow Cytometry System Market
      4.4.1 Bargaining Power of Suppliers
      4.4.2 Bargaining Power of Buyers
      4.4.3 Threat of Substitution
      4.4.4 Threat of New Entrants
      4.4.5 Competitive Rivalry
   4.5 Global Flow Cytometry System Market Size & Forecast, 2017-2027
      4.5.1 Flow Cytometry System Market Size and Y-o-Y Growth
      4.5.2 Flow Cytometry System Market Absolute $ Opportunity
   4.6 Pricing Analysis & Forecast, By Technology, 2017-2027
   4.7 Global Flow Cytometry System Market: Impact Of Key Regulations
Chapter 5 Global Flow Cytometry System Market Analysis and Forecast By Technology
   5.1 Introduction
      5.1.1 Key Market Trends & Growth Opportunities By Technology
      5.1.2 Basis Point Share (BPS) Analysis By Technology
      5.1.3 Absolute $ Opportunity Assessment By Technology
   5.2 Flow Cytometry System Market Size Forecast By Technology
      5.2.1 Cell-based Flow Cytometry
      5.2.2 Bead-based Flow Cytometry
   5.3 Market Attractiveness Analysis By Technology
Chapter 6 Global Flow Cytometry System Market Analysis and Forecast By Product and Service
   6.1 Introduction
      6.1.1 Key Market Trends & Growth Opportunities By Product and Service
      6.1.2 Basis Point Share (BPS) Analysis By Product and Service
      6.1.3 Absolute $ Opportunity Assessment By Product and Service
   6.2 Flow Cytometry System Market Size Forecast By Product and Service
      6.2.1 Reagents and Consumables
      6.2.2 Instruments
         6.2.2.1 Cell Analyzers
            6.2.2.1.1 High-range
            6.2.2.1.2 Mid-range
            6.2.2.1.3 Low-range
         6.2.2.2 Cell Sorters
            6.2.2.2.1 High-range
            6.2.2.2.2 Mid-range
            6.2.2.2.3 Low-range
      6.2.3 Services
      6.2.4 Software
      6.2.5 Accessories
   6.3 Market Attractiveness Analysis By Product and Service
Chapter 7 Global Flow Cytometry System Market Analysis and Forecast By Application
   7.1 Introduction
      7.1.1 Key Market Trends & Growth Opportunities By Application
      7.1.2 Basis Point Share (BPS) Analysis By Application
      7.1.3 Absolute $ Opportunity Assessment By Application
   7.2 Flow Cytometry System Market Size Forecast By Application
      7.2.1 Research Applications
         7.2.1.1 Pharmaceuticals and Biotechnology
            7.2.1.1.1 Drug Discovery
            7.2.1.1.2 Stem Cell Research
            7.2.1.1.3 In Vitro Toxicity Testing
         7.2.1.2 Immunology
         7.2.1.3 Cell Sorting
         7.2.1.4 Apoptosis
         7.2.1.5 Cell Cycle Analysis
         7.2.1.6 Cell Viability
         7.2.1.7 Cell Counting
         7.2.1.8 Other
      7.2.2 Research Applications
         7.2.2.1 Clinical Applications
         7.2.2.2 Cancer Diagnostics
         7.2.2.3 Hematology
         7.2.2.4 Immunodeficiency Diseases
         7.2.2.5 Organ Transplantation
         7.2.2.6 Other Clinical Applications
      7.2.3 Industrial Applications
   7.3 Market Attractiveness Analysis By Application
Chapter 8 Global Flow Cytometry System Market Analysis and Forecast By End-user
   8.1 Introduction
      8.1.1 Key Market Trends & Growth Opportunities By End-user
      8.1.2 Basis Point Share (BPS) Analysis By End-user
      8.1.3 Absolute $ Opportunity Assessment By End-user
   8.2 Flow Cytometry System Market Size Forecast By End-user
      8.2.1 Commercial Organizations
      8.2.2 Hospitals
      8.2.3 Academic Institutes
      8.2.4 Clinical Testing Labs
   8.3 Market Attractiveness Analysis By End-user
Chapter 9 Global Flow Cytometry System Market Analysis and Forecast by Region
   9.1 Introduction
      9.1.1 Key Market Trends & Growth Opportunities by Region
      9.1.2 Basis Point Share (BPS) Analysis by Region
      9.1.3 Absolute $ Opportunity Assessment by Region
   9.2 Flow Cytometry System Market Size Forecast by Region
      9.2.1 North America
      9.2.2 Europe
      9.2.3 Asia Pacific
      9.2.4 Latin America
      9.2.5 Middle East & Africa (MEA)
   9.3 Market Attractiveness Analysis by Region
Chapter 10 Coronavirus Disease (COVID-19) Impact
   10.1 Introduction
   10.2 Current & Future Impact Analysis
   10.3 Economic Impact Analysis
   10.4 Government Policies
   10.5 Investment Scenario
Chapter 11 North America Flow Cytometry System Analysis and Forecast
   11.1 Introduction
   11.2 North America Flow Cytometry System Market Size Forecast by Country
      11.2.1 U.S.
      11.2.2 Canada
   11.3 Basis Point Share (BPS) Analysis by Country
   11.4 Absolute $ Opportunity Assessment by Country
   11.5 Market Attractiveness Analysis by Country
   11.6 North America Flow Cytometry System Market Size Forecast By Technology
      11.6.1 Cell-based Flow Cytometry
      11.6.2 Bead-based Flow Cytometry
   11.7 Basis Point Share (BPS) Analysis By Technology
   11.8 Absolute $ Opportunity Assessment By Technology
   11.9 Market Attractiveness Analysis By Technology
   11.10 North America Flow Cytometry System Market Size Forecast By Product and Service
      11.10.1 Reagents and Consumables
      11.10.2 Instruments
         11.10.2.1 Cell Analyzers
         11.10.2.2 Cell Sorters
      11.10.3 Services
      11.10.4 Software
      11.10.5 Accessories
   11.11 Basis Point Share (BPS) Analysis By Product and Service
   11.12 Absolute $ Opportunity Assessment By Product and Service
   11.13 Market Attractiveness Analysis By Product and Service
   11.14 North America Flow Cytometry System Market Size Forecast By Application
      11.14.1 Research Applications
         11.14.1.1 Pharmaceuticals and Biotechnology
         11.14.1.2 Immunology
         11.14.1.3 Cell Sorting
         11.14.1.4 Apoptosis
         11.14.1.5 Cell Cycle Analysis
         11.14.1.6 Cell Viability
         11.14.1.7 Cell Counting
         11.14.1.8 Other
      11.14.2 Clinical Applications
         11.14.2.1 Cancer Diagnostics
         11.14.2.2 Hematology
         11.14.2.3 Immunodeficiency Diseases
         11.14.2.4 Organ Transplantation
         11.14.2.5  Other Clinical Applications
      11.14.3 Industrial Applications
   11.15 Basis Point Share (BPS) Analysis By Application
   11.16 Absolute $ Opportunity Assessment By Application
   11.17 Market Attractiveness Analysis By Application
   11.18 North America Flow Cytometry System Market Size Forecast By End-user
      11.18.1 Commercial Organizations
      11.18.2 Hospitals
      11.18.3 Academic Institutes
      11.18.4 Clinical Testing Labs
   11.19 Basis Point Share (BPS) Analysis By End-user
   11.20 Absolute $ Opportunity Assessment By End-user
   11.21 Market Attractiveness Analysis By End-user
Chapter 12 Europe Flow Cytometry System Analysis and Forecast
   12.1 Introduction
   12.2 Europe Flow Cytometry System Market Size Forecast by Country
      12.2.1 Germany
      12.2.2 France
      12.2.3 Italy
      12.2.4 U.K.
      12.2.5 Spain
      12.2.6 Russia
      12.2.7 Rest of Europe
   12.3 Basis Point Share (BPS) Analysis by Country
   12.4 Absolute $ Opportunity Assessment by Country
   12.5 Market Attractiveness Analysis by Country
   12.6 Europe Flow Cytometry System Market Size Forecast By Technology
      12.6.1 Cell-based Flow Cytometry
      12.6.2 Bead-based Flow Cytometry
   12.7 Basis Point Share (BPS) Analysis By Technology
   12.8 Absolute $ Opportunity Assessment By Technology
   12.9 Market Attractiveness Analysis By Technology
   12.10 Europe Flow Cytometry System Market Size Forecast By Product and Service
      12.10.1 Reagents and Consumables
      12.10.2 Instruments
         12.10.2.1 Cell Analyzers
         12.10.2.2 Cell Sorters
      12.10.3 Services
      12.10.4 Software
      12.10.5 Accessories
   12.11 Basis Point Share (BPS) Analysis By Product and Service
   12.12 Absolute $ Opportunity Assessment By Product and Service
   12.13 Market Attractiveness Analysis By Product and Service
   12.14 Europe Flow Cytometry System Market Size Forecast By Application
      12.14.1 Research Applications
         12.14.1.1 Pharmaceuticals and Biotechnology
         12.14.1.2 Immunology
         12.14.1.3 Cell Sorting
         12.14.1.4 Apoptosis
         12.14.1.5 Cell Cycle Analysis
         12.14.1.6 Cell Viability
         12.14.1.7 Cell Counting
         12.14.1.8 Other
      12.14.2 Clinical Applications
         12.14.2.1 Cancer Diagnostics
         12.14.2.2 Hematology
         12.14.2.3 Immunodeficiency Diseases
         12.14.2.4 Organ Transplantation
         12.14.2.5 Other Clinical Applications
      12.14.3 Industrial Applications
   12.15 Basis Point Share (BPS) Analysis By Application
   12.16 Absolute $ Opportunity Assessment By Application
   12.17 Market Attractiveness Analysis By Application
   12.18 Europe Flow Cytometry System Market Size Forecast By End-user
      12.18.1 Commercial Organizations
      12.18.2 Hospitals
      12.18.3 Academic Institutes
      12.18.4 Clinical Testing Labs
   12.19 Basis Point Share (BPS) Analysis By End-user
   12.20 Absolute $ Opportunity Assessment By End-user
   12.21 Market Attractiveness Analysis By End-user
Chapter 13 Asia Pacific Flow Cytometry System Analysis and Forecast
   13.1 Introduction
   13.2 Asia Pacific Flow Cytometry System Market Size Forecast by Country
      13.2.1 China
      13.2.2 Japan
      13.2.3 South Korea
      13.2.4 India
      13.2.5 Australia
      13.2.6 South East Asia (SEA)
      13.2.7 Rest of Asia Pacific (APAC)
   13.3 Basis Point Share (BPS) Analysis by Country
   13.4 Absolute $ Opportunity Assessment by Country
   13.5 Market Attractiveness Analysis by Country
   13.6 Asia Pacific Flow Cytometry System Market Size Forecast By Technology
      13.6.1 Cell-based Flow Cytometry
      13.6.2 Bead-based Flow Cytometry
   13.7 Basis Point Share (BPS) Analysis By Technology
   13.8 Absolute $ Opportunity Assessment By Technology
   13.9 Market Attractiveness Analysis By Technology
   13.10 Asia Pacific Flow Cytometry System Market Size Forecast By Product and Service
      13.10.1 Reagents and Consumables
      13.10.2 Instruments
         13.10.2.1 Cell Analyzers
         13.10.2.2 Cell Sorters
      13.10.3 Services
      13.10.4 Software
      13.10.5 Accessories
   13.11 Basis Point Share (BPS) Analysis By Product and Service
   13.12 Absolute $ Opportunity Assessment By Product and Service
   13.13 Market Attractiveness Analysis By Product and Service
   13.14 Asia Pacific Flow Cytometry System Market Size Forecast By Application
      13.14.1 Research Applications
         13.14.1.1 Pharmaceuticals and Biotechnology
         13.14.1.2 Immunology
         13.14.1.3 Cell Sorting
         13.14.1.4 Apoptosis
         13.14.1.5 Cell Cycle Analysis
         13.14.1.6 Cell Viability
         13.14.1.7 Cell Counting
         13.14.1.8 Other
      13.14.2 Clinical Applications
         13.14.2.1 Cancer Diagnostics
         13.14.2.2 Hematology
         13.14.2.3 Immunodeficiency Diseases
         13.14.2.4 Organ Transplantation
         13.14.2.5 Other Clinical Applications
      13.14.3 Industrial Applications
   13.15 Basis Point Share (BPS) Analysis By Application
   13.16 Absolute $ Opportunity Assessment By Application
   13.17 Market Attractiveness Analysis By Application
   13.18 Asia Pacific Flow Cytometry System Market Size Forecast By End-user
      13.18.1 Commercial Organizations
      13.18.2 Hospitals
      13.18.3 Academic Institutes
      13.18.4 Clinical Testing Labs
   13.19 Basis Point Share (BPS) Analysis By End-user
   13.20 Absolute $ Opportunity Assessment By End-user
   13.21 Market Attractiveness Analysis By End-user
Chapter 14 Latin America Flow Cytometry System Analysis and Forecast
   14.1 Introduction
   14.2 Latin America Flow Cytometry System Market Size Forecast by Country
      14.2.1 Brazil
      14.2.2 Mexico
      14.2.3 Rest of Latin America (LATAM)
   14.3 Basis Point Share (BPS) Analysis by Country
   14.4 Absolute $ Opportunity Assessment by Country
   14.5 Market Attractiveness Analysis by Country
   14.6 Latin America Flow Cytometry System Market Size Forecast By Technology
      14.6.1 Cell-based Flow Cytometry
      14.6.2 Bead-based Flow Cytometry
   14.7 Basis Point Share (BPS) Analysis By Technology
   14.8 Absolute $ Opportunity Assessment By Technology
   14.9 Market Attractiveness Analysis By Technology
   14.10 Latin America Flow Cytometry System Market Size Forecast By Product and Service
      14.10.1 Reagents and Consumables
      14.10.2 Instruments
         14.10.2.1 Cell Analyzers
         14.10.2.2 Cell Sorters
      14.10.3 Services
      14.10.4 Software
      14.10.5 Accessories
   14.11 Basis Point Share (BPS) Analysis By Product and Service
   14.12 Absolute $ Opportunity Assessment By Product and Service
   14.13 Market Attractiveness Analysis By Product and Service
   14.14 Latin America Flow Cytometry System Market Size Forecast By Application
      14.14.1 Research Applications
         14.14.1.1 Pharmaceuticals and Biotechnology
         14.14.1.2 Immunology
         14.14.1.3 Cell Sorting
         14.14.1.4 Apoptosis
         14.14.1.5 Cell Cycle Analysis
         14.14.1.6 Cell Viability
         14.14.1.7 Cell Counting
         14.14.1.8 Other
      14.14.2 Clinical Applications
         14.14.2.1 Cancer Diagnostics
         14.14.2.2 Hematology
         14.14.2.3 Immunodeficiency Diseases
         14.14.2.4 Organ Transplantation
         14.14.2.5 Other Clinical Applications
      14.14.3 Industrial Applications
   14.15 Basis Point Share (BPS) Analysis By Application
   14.16 Absolute $ Opportunity Assessment By Application
   14.17 Market Attractiveness Analysis By Application
   14.18 Latin America Flow Cytometry System Market Size Forecast By End-user
      14.18.1 Commercial Organizations
      14.18.2 Hospitals
      14.18.3 Academic Institutes
      14.18.4 Clinical Testing Labs
   14.19 Basis Point Share (BPS) Analysis By End-user
   14.20 Absolute $ Opportunity Assessment By End-user
   14.21 Market Attractiveness Analysis By End-user
Chapter 15 Middle East & Africa (MEA) Flow Cytometry System Analysis and Forecast
   15.1 Introduction
   15.2 Middle East & Africa (MEA) Flow Cytometry System Market Size Forecast by Country
      15.2.1 Saudi Arabia
      15.2.2 South Africa
      15.2.3 UAE
      15.2.4 Rest of Middle East & Africa (MEA)
   15.3 Basis Point Share (BPS) Analysis by Country
   15.4 Absolute $ Opportunity Assessment by Country
   15.5 Market Attractiveness Analysis by Country
   15.6 Middle East & Africa (MEA) Flow Cytometry System Market Size Forecast By Technology
      15.6.1 Cell-based Flow Cytometry
      15.6.2 Bead-based Flow Cytometry
   15.7 Basis Point Share (BPS) Analysis By Technology
   15.8 Absolute $ Opportunity Assessment By Technology
   15.9 Market Attractiveness Analysis By Technology
   15.10 Middle East & Africa (MEA) Flow Cytometry System Market Size Forecast By Product and Service
      15.10.1 Reagents and Consumables
      15.10.2 Instruments
         15.10.2.1 Cell Analyzers
         15.10.2.2 Cell Sorters
      15.10.3 Services
      15.10.4 Software
      15.10.5 Accessories
   15.11 Basis Point Share (BPS) Analysis By Product and Service
   15.12 Absolute $ Opportunity Assessment By Product and Service
   15.13 Market Attractiveness Analysis By Product and Service
   15.14 Middle East & Africa (MEA) Flow Cytometry System Market Size Forecast By Application
      15.14.1 Research Applications
         15.14.1.1 Pharmaceuticals and Biotechnology
         15.14.1.2 Immunology
         15.14.1.3 Cell Sorting
         15.14.1.4 Apoptosis
         15.14.1.5 Cell Cycle Analysis
         15.14.1.6 Cell Viability
         15.14.1.7 Cell Counting
         15.14.1.8 Other
      15.14.2 Clinical Applications
         15.14.2.1 Cancer Diagnostics
         15.14.2.2 Hematology
         15.14.2.3 Immunodeficiency Diseases
         15.14.2.4 Organ Transplantation
         15.14.2.5 Other Clinical Applications
      15.14.3 Industrial Applications
   15.15 Basis Point Share (BPS) Analysis By Application
   15.16 Absolute $ Opportunity Assessment By Application
   15.17 Market Attractiveness Analysis By Application
   15.18 Middle East & Africa (MEA) Flow Cytometry System Market Size Forecast By End-user
      15.18.1 Commercial Organizations
      15.18.2 Hospitals
      15.18.3 Academic Institutes
      15.18.4 Clinical Testing Labs
   15.19 Basis Point Share (BPS) Analysis By End-user
   15.20 Absolute $ Opportunity Assessment By End-user
   15.21 Market Attractiveness Analysis By End-user
Chapter 16 Competition Landscape
   16.1 Flow Cytometry System Market: Competitive Dashboard
   16.2 Global Flow Cytometry System Market: Market Share Analysis, 2020
   16.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
      16.3.1 Agilent Technologies, Inc. 
      16.3.2 Apogee Flow Systems
      16.3.3 Beckman Coulter, Inc.
      16.3.4 Becton, Dickinson and Company
      16.3.5 Bio-Rad Laboratories, Inc.
      16.3.6 bioMérieux S.A.
      16.3.7 Cytek Biosciences 
      16.3.8 Cytonome/ST LLC
      16.3.9 Enzo Life Sciences, Inc.
      16.3.10 GE Healthcare
      16.3.11 Life Technologies Corporation
      16.3.12 Luminex Corporation 
      16.3.13 Mechatronics
      16.3.14 Merck KGaA
      16.3.15 Miltenyi Biotec GmbH
      16.3.16 Sony Biotechnology, Inc.
      16.3.17 Stratedigm, Inc.
      16.3.18 Sysmex Partec GmbH
      16.3.19 Takara Bio Inc.
      16.3.20 Thermo Fisher Scientific, Inc.
Key Segments Covered
By Technology
  • Cell-based flow cytometry system
  • Bead-based Flow cytometry system
By Products and Services
  • Reagents and Consumables
  • Instruments
  • Cell Analyzers
      • High-range
      • Mid-range
      • Low-range
  • Cell Sorters
      • High-range
      • Mid-range
      • Low-range
  • Services
  • Software
  • Accessories
By Applications
  • Research Applications
    • Pharmaceuticals and Biotechnology
      • Drug Discovery
      • Stem Cell Research
      • In vitro toxicity testing
    • Immunology
    • Cell Sorting
    • Apoptosis
    • Cell Cycle Analysis
    • Cell Viability
    • Cell Counting
    • Other
  • Clinical Applications
  • Cancer Diagnostics
  • Hematology
  • Immunodeficiency Diseases
  • Organ Transplantation
  • Other Clinical Applications
  • Industrial Applications
By End-Users
  • Commercial Organizations
  • Hospitals
  • Academic Institutes
  • Clinical Testing Labs
By Region
  • North America
    • US.
    • Canada
  • Latin America
    • Brazil
    • Mexico
    • Rest of Latin America
  • Europe
    • U.K.
    • France
    • Germany
    • Italy
    • Spain
    • Russia
    • Rest of the Europe
  • Asia Pacific
    • China
    • Japan
    • South Korea
    • India
    • Australia
    • Rest of Asia Pacific
  • Middle East & Africa (MEA)
    • Saudi Arabia
    • South Africa
    • UAE
    • Rest of MEA

Key Market Players Profiled in the Report
  • Danaher Corp
  • Apogee Flow Systems
  • Becton, Dickinson and Company
  • BioMérieux S.A.
  • Cytek Biosciences
  • CytonomeST LLC
  • Corning Incorporated
  • Sartorius AG
  • Enzo Life Sciences, Inc.
  • GE Healthcare
  • Luminex Corporation
  • Agilent Technologies, Inc
  • Bio-Rad Laboratories, Inc.
  • Harvard Bioscience, Inc.
  • Merck KGaA
  • QIAGEN N.V.
  • Takara Bio Inc.
  • Thermo Fisher Scientific Inc.
  • Sony Biotechnology Inc.
  • Miltenyi Biotec
  • Sysmex Corporation
  • Stratedigm, Inc
  • Key players in the market include Becton, Dickinson and Company, Bio-Rad Laboratories, Inc., Merck KGaA, Danahar Corporation, Agilent Technologies, Inc. These companies are considered manufacturers of flow cytometry system market based on their revenue, research development (R&D) activities, regional presence, and supply chain management system.
  • The players are adopting key strategies such as acquisition, and geographical expansion where potential opportunity is added in the company’s capacity.
  • For instance, In March 2020, Danaher Corp acquired Biopharma business of General Electric Company for customer base acquisition across the globe.
  • In July 2019, BioMérieux S.A. acquired Invisible Sentinel, a US-based company specialized in food & beverage molecular testing for expanding business in North America.

Global Flow Cytometry System Market By Key Players

Buy Report

FAQ Section

Some frequently asked quetions about this report!

Additional company profiles can be provided on request.

Yes, the report covers product specific information such as cell-based flow cytometry systems, and bead-based flow cytometry systems, etc.

According to this Growth Market Reports report, the market from flow cytometry system market shall probably to register a CAGR of 10.0% during forecast period 2020-2027, with an anticipated valuation of USD 9,452.6 million by the end of the 2027.

The rising adoption of AI in flow cytometry and rise in the investments in research and development, for the detection of diseases are expected to drive the market growth during forecast period.

Biotech and pharmaceutical industries, research and academic Institutes, hospitals and diagnostic centers are the key application that are driving the flow cytometry system market.

Factors such as competitive strength and market positioning are key areas considered while selecting top companies to be profiled.

The market is expected to project a growth of over 12.6% in 2020 owing to the positive impact of COVID-19 pandemic on the flow cytometry system market. The rising adoption of flow cytometry system by biopharmaceutical companies boost the growth of the segment.

The base year considered for the global flow cytometry system market report is 2019. The complete analysis period is 2017 to 2027, wherein, 2017 & 2018 are the historic years and the forecast is provided from 2020 to 2027.

Major manufactures includes Danaher Corp, and Becton, Dickinson and Company are the key players operating in the market.